![Thérèse Croughs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thérèse Croughs
Director/Board Member at
Bioxodes SA
Profile
Thérèse Croughs is a Non-Executive Director at Bioxodes SA. She was previously the Chief Medical Officer & Managing Director at Cytheris SA, a Clinical Project Leader at Bayer AG, and a Principal at Valerio Therapeutics SA from 2004 to 2013.
From 2015 to 2019, she served as the Chief Medical Officer at Neovacs SA. Dr. Croughs holds a doctorate degree from the Université Catholique de Louvain.
Thérèse Croughs active positions
| Companies | Position | Start |
|---|---|---|
Bioxodes SA
 Bioxodes SA BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapeutics targeting thrombo-inflammation | Director/Board Member | - |
Former positions of Thérèse Croughs
| Companies | Position | End |
|---|---|---|
| NEOVACS | Chief Tech/Sci/R&D Officer | 2019-05-31 |
| BAYER AG | Corporate Officer/Principal | - |
| VALERIO THERAPEUTICS | Corporate Officer/Principal | - |
Cytheris SA
 Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation | Chief Tech/Sci/R&D Officer | - |
Training of Thérèse Croughs
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Cytheris SA
Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation | Health Technology |
Neovacs SA
 Neovacs SA Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapies | Health Technology |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioxodes SA
Bioxodes SA BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapeutics targeting thrombo-inflammation | Health Technology |
- Stock Market
- Insiders
- Thérèse Croughs
